Abstract
Botulinum toxin therapy is now established in the field of ophthalmology for treatment of blepharospasm ,hemifacial spasm and strabismus and may help certain types of nystagmus, apraxia of the eyelid opening, eyelid myokyomia, facial nerve synkinesis, lacrimal hypersecretion syndromes, eyelid retraction, spastic entropion and corneal protective ptosis. In this chapter, I discuss these indications.
Keywords
- Botulinum toxinBotulinum Toxin
- Facial Nerve Synkinesis
- Hemifacial Spasm
- Spastic Entropion
- Benign Essential Blepharospasm
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–70.
Scott AB, Magoon EH, McNeer KW, Stager DR. Botulinum treatment of strabismus in children. Trans Am Ophthalmol Soc. 1989;87:174–84.
Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology. 1988;95:1529–34.
Humeau Y, Doussau F, Grant NJ, et al. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochemistry. 2000;82:427–46.
Vissenberg I, Dieleman-Smet H, Tassignon MJ. Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias. Bull Soc Belge Ophthalmol. 1993;248:77–82.
Dutton JJ, Fowler AM. Botulinum Toxin in Ophthalmology. Surv Ophthalmol. 2007;52:13–31.
Carruthers A, Carruthers J. Botulinum toxin type A for the treatment of glabellar rhytides. Dermatol Clin. 2004;22:137–44.
Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103:347–50.
Shorr N, Seiff SR, Kopelman J. The use of botulinum toxin in blepharospasm. Am J Ophthalmol. 1985;99:542–6.
Cohen DA, Savino PJ, Stern MB, et al. Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol. 1986;9:415–29.
Dutton JJ, Buckley EG. Botulinum toxin in the management of blepharospasm. Arch Neurol. 1986;43:380–2.
Engstrom PF, Arnoult JB, Mazow ML, et al. Effectiveness of botulinum toxin therapy for essential blepharospasm. Ophthalmology. 1987;17:971–5.
Elston JS. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injection. Br J Ophthalmol. 1987;71:664–8.
Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid ectropion. Can J Neurol Sci. 1987;14:42–5.
Cakmur R, Ozturk V, Uzunel F, et al. Comparison of pre-septal and pre-tarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol. 2002;249:64–8.
Calace P, Cortese G, Piscopo R, et al. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol. 2003;13:331–6.
Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol. 1991;36:28–46.
Gonnering RS. Treatment of hemifacial spasm with botulinum A toxin: results and rationale. Ophthal Plast Reconstr Surg. 1986;2:143–6.
Taylor JD, Kraft SP, Kazdan MS, et al. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol. 1991;26:133–8.
Sorgun MH, Yilmaz R, Akin YA, Mercan FN, et al. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci. 2015;22(8):1319–25.
McNeer KW, Tucker MG, Guerry CH, et al. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin. J Pediatr Ophthalmol Strabismus. 2003;40:288–92.
Campos EC, Schiavi C, Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J Pediatr Ophthalmol Strabismus. 2000;37:328–32.
Dawson EL, Marshman WE, Adams GG. The role of botulinum toxin A in acute-onset esotropia. Ophthalmology. 1999;106:1727–30.
Dawson EL, Lee JP. Does botulinum toxin have a role in the treatment of small angle esotropia? Strabismus. 2004;12:257–60.
Holmes JM, Droste PJ, Beck RW, et al. The natural history of acute traumatic sixth nerve palsy or paresis. J AAPOS. 1998;2:265–8.
Holmes JM, Beck RW, Kip KE, et al. Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. J AAPOS. 2000;4:145–9.
Holmes JM, Leske DA, Christiansen SP. Initial treatment outcomes in chronic sixth nerve palsy. J AAPOS. 2001;5:370–6.
Rowe FL, Noonan CP. Botulinum toxin for the treatment of strabismus (review). Cochrane Database Syst Rev 2012(2):1–33. Wiley, Art. No:CD006499.
Han SH, Lew H, Jeong CW, et al. Effect of botulinum toxin A chemodenervation in sensory strabismus. J Pediatr Ophthalmol Strabismus. 2001;38:68–71.
Kerr NC, Hoehn MB. Botulinum toxin for sixth nerve palsies in children with brain tumors. J AAPOS. 2001;5:21–5.
Garnham LM, Lawqson JM, O’Neill D, et al. Botulinum toxin in fourth nerve palsies. Aust NZ J Ophthalmology. 1986;93:917–23.
Flores-Reyes EM, Castillo-Lopez MG, Toledo-Silva R, et al. Botulinum toxin type A as a treatment of partially accommodative esotropia. Arch Soc Esp Oftalmol. 2016;91(3):120–4.
Etezad Razavi M, Sharifi M, Armanfar F. Efficacy of botulinum toxin in the treatment of intermittent exotropia. Strabismus. 2014;22(4):176–81.
Saunte JP, Holmes JM. Sustained improvement of reading symptoms following botulinum toxin A injection for convergence insufficiency. Strabismus. 2014;22(3):95–9.
Christiansen SP, Chandler DL, Lee KA, et al. Tonic pupil after botulinum toxin-A injection for treatment of esotropia in children. J AAPOS. 2016;20(1):78–81.
Caruthers J, Carruthers A, et al. The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus. 1995;32:306–87.
Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol. 1994;112:1320–4.
Helveston EM, Pogrebniak AE. Treatment of acquired nystagmus with botulinum A toxin. Am J Ophthalmol. 1988;106:584–6.
Ruben S, Dunlop IS, Elston J. Retrobulbar botulinum for treatment of oscillopsia. Aust NZ J Ophthalmol. 1994;22:65–7.
Ruben ST, Lee JP, O’Neil D, et al. The use of botulinum toxin for the treatment of oscillopsia. Ophthalmology. 1994;101:783–7.
Tomsak RL, Remler BF, Averbuch-Heller L, et al. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am J Ophthalmol. 1995;119:489–96.
Forget R, Tozlovanu V, Iancu A, et al. Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening. Neurology. 2002;58:1843–6.
Boghen D, Tozlovanu V, Iancu A, et al. Botulinum toxin therapy for apraxia of lid opening. Ann N Y Acad Sci. 2002;956:482–3.
Banik R, Miller NR. Chronic myokymia limited to the eyelid is a benign condition. J Neuroophthalmol. 2004;24:290–2.
Jordan DR, Anderson RL, Thiese SM, et al. Intractable orbicularis myokymia: treatment alternatives. Ophthalmic Surg. 1989;20:280–3.
Mountain RE, Murray JA, Quaba A. Management of facial synkinesis with botulinum toxin injection. Clin Otolaryngol Allied Sci. 1992;17:223–4.
Roggenkamper P, Laskawi R, Damanz W, et al. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol. 1994;86:395–402.
Chua CN, Quhill F, Jones E, et al. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit. 2004;23:213–8.
Kinkelin I, Hund M, Naumann M, et al. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol. 2000;143:824–7.
Kyrmizakis DE, Pangalos A, Papadakis CE, et al. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. J Oral Maxillofac Surg. 2004;62:840–4.
Hofmann RJ. Treatment of Frey’s syndrome (gustatory sweating) and crocodile tears (gustatory epiphora) with purified botulinum toxin. Ophthal Plast Reconstr Surg. 2000;16:289–91.
Keegan DJ, Geerlin G, Lee JP, et al. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol. 2002;86:43–6.
Scott AB. Injection treatment of endocrine orbital myopathy. Doc Ophthalmol. 1989;58:141–5.
Biglan AW. Control of eyelid retraction associated with Graves’ disease with botulinum A toxin. Ophthalmic Surg. 1994;25:186–8.
Traisk F, Tallstedt L. Thyroid associated ophthalmology: botulinum toxin A in the treatment of upper eyelid retraction—a pilot study. Acta Ophthalmol Scand. 2001;79:585–8.
Morgenstern KE, Evanchan J, Foster JA, et al. Botulinum toxin type A for dysthyroid upper eyelid retraction. Ophthal Plast Reconstr Surg. 2004;20:181–5.
Shih MJ, Liao SL, Lu HY. A single transcutaneous injection with Botox for dysthyroid lid retraction. Eye. 2004;18:466–9.
Neetens A, Rubbens MC, Smet H. Botulinum A-toxin treatment of spasmodic entropion of the lower eyelid. Bull Soc Belge Ophthalmol. 1987;224:105–9.
Adams GG, Kirkness CM, Lee JP. Botulinum toxin A induced protective ptosis. Eye. 1987;1:603–8.
Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A when used to produce protective ptosis. Clin Experiment Ophthalmol. 2001;29:394–9.
Carruthers J, Fagien S, Matarasso SL, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114:1S–22S.
Fagien S. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg. 2003;112:6S–18S.
Chen AH, Frankel AS. Altering brow contour with botulinum toxin. Facial Plast Surg Clin North Am. 2003;11:457–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Galvin, J.A. (2018). Clinical Uses of the Botulinum Toxin and Ophthalmology. In: Jabbari, B. (eds) Botulinum Toxin Treatment in Clinical Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-56038-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-56038-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56037-3
Online ISBN: 978-3-319-56038-0
eBook Packages: MedicineMedicine (R0)